- FT NewsFT News
- Press releasesPress releases
- P&G to buy Merck’s consumer health business for €3.4bn
- Stockpickers’ chance has arrived, but will they seize it?
- Best of Lex: your weekly round-up
- Norway oil fund posts $131bn return for 2017
- Buffett/Teva: below my pay grade
- Unilever HQ move would be motivated by more than Brexit
- Stocks to watch: InterContinental, HSBC, Dunelm, Hikma, Temenos
- Week ahead: Fed minutes, Walmart, Buffett investor day
- Teva shares jump after Berkshire Hathaway reveals $358m stake
- Teva warns on revenue amid tough US drug pricing
As of last trade,
Teva Pharmaceutical Industries Ltd (TEV:DUS) traded at 14.75, 53.58% above the 52 week low of 9.60 set on Nov 02, 2017.
9.60Nov 02 201729.52Jul 05 2017
Markit short selling activity
|Annual div (ADY)||0.7144 |
|Annual div yield (ADY)||4.98%|
|Div ex-date||Nov 27 2017|
|Div pay-date||Dec 12 2017|
Data delayed at least 15 minutes, as of Apr 23 2018 07:05 BST.